UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 152

Sortiert nach

Prediction of Contact Residues in Anti-HIV Neutralizing Antibody by Deep Learning

Japanese Journal of Infectious Diseases, 2020/05/29, Vol.73(3), pp.235-241

2020

Volltextzugriff (PDF)

Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron

Scientific reports, 2023-10, Vol.13 (1), p.17404-17404, Article 17404

2023

Volltextzugriff (PDF)

Sensitivity to a CD4 mimic of a consensus clone of monkey-adapted CCR5-tropic SHIV-MK38C

Virology (New York, N.Y.), 2023-01, Vol.578, p.171-179

2023

Volltextzugriff (PDF)

Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2

International journal of molecular sciences, 2024-01, Vol.25 (2), p.1353

2024

Volltextzugriff (PDF)

Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitors

Bioorganic & medicinal chemistry, 2022-12, Vol.76, p.117083-117083, Article 117083

2022

Volltextzugriff (PDF)

Osteoporosis-Related Fractures in HIV-Infected Patients Receiving Long-Term Tenofovir Disoproxil Fumarate: An Observational Cohort Study

Drug safety, 2018-09, Vol.41 (9), p.843-848

2018

Volltextzugriff (PDF)

Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors

Bioorganic & medicinal chemistry, 2022-02, Vol.56, p.116616-116616, Article 116616

2022

Volltextzugriff (PDF)

Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop

PloS one, 2012-05, Vol.7 (5), p.e37530-e37530

2012

Volltextzugriff (PDF)

Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.437-450

2016

Volltextzugriff (PDF)

Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates

Journal of virology, 2023-01, Vol.97 (1), p.e0163822

2023

Volltextzugriff (PDF)

Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19

Cell reports (Cambridge), 2021-07, Vol.36 (2), p.109385-109385, Article 109385

2021

Volltextzugriff (PDF)

Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG

Retrovirology, 2021-08, Vol.18 (1), p.23-23, Article 23

2021

Volltextzugriff (PDF)

Partial Splenic Embolization in a Patient with Hemophilia A and Severe Thrombocytopenia: A Case Report

Hematology reports, 2024-03, Vol.16 (2), p.185-192

2024

Volltextzugriff (PDF)

Flexibility of small molecular CD4 mimics as HIV entry inhibitors

Bioorganic & medicinal chemistry, 2018-11, Vol.26 (21), p.5664-5671

2018

Volltextzugriff (PDF)

Clonality of HIV-1– and HTLV-1–Infected Cells in Naturally Coinfected Individuals

The Journal of infectious diseases, 2022-01, Vol.225 (2), p.317-326

2022

Volltextzugriff (PDF)

Apolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophages

PLoS pathogens, 2018-11, Vol.14 (11), p.e1007372-e1007372

2018

Volltextzugriff (PDF)

Impact of maraviroc-resistant and low-CCR5-adapted mutations induced by in vitro passage on sensitivity to anti-envelope neutralizing antibodies

Journal of general virology, 2014-08, Vol.95 (Pt 8), p.1816-1826

2014

Volltextzugriff (PDF)

Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors

ChemMedChem, 2016-04, Vol.11 (8), p.940-946

2016

Volltextzugriff (PDF)

Phenotypic and Genotypic Co-receptor Tropism Testing in HIV-1 Epidemic Region of Tanzania Where Multiple Non-B Subtypes Co-circulate

Frontiers in microbiology, 2021-07, Vol.12, p.703041-703041

2021

Volltextzugriff (PDF)

Enhanced Exposure of Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Epitopes through Binding of CD4 Mimetic Compounds

Journal of Virology, 2010-08, Vol.84 (15), p.7558-7568

2010

Volltextzugriff (PDF)

The role of conventional antibodies targeting the CD4 binding site and CD4-induced epitopes in the control of HIV-1 CRF01_AE viruses

Biochemical and biophysical research communications, 2019-01, Vol.508 (1), p.46-51

2019

Volltextzugriff (PDF)

Complementary and synergistic activities of anti-V3, CD4bs and CD4i antibodies derived from a single individual can cover a wide range of HIV-1 strains

Virology (New York, N.Y.), 2015-01, Vol.475, p.187-203

2015

Volltextzugriff (PDF)

A minimally cytotoxic CD4 mimic as an HIV entry inhibitor

Bioorganic & medicinal chemistry letters, 2016-01, Vol.26 (2), p.397-400

2016

Volltextzugriff (PDF)

The Prevalence of High Antiretroviral Coverage and Viral Suppression in Japan: an Excellent Profile for a Downstream Human Immunodeficiency Virus Care Spectrum

Japanese Journal of Infectious Diseases, 2017, Vol.70(2), pp.158-160

2017

Volltextzugriff (PDF)

CD4 mimics as HIV entry inhibitors: Lead optimization studies of the aromatic substituents

Bioorganic & medicinal chemistry, 2013-05, Vol.21 (9), p.2518-2526

2013

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(142)

Publikationsform

Artikel
(151)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(114)
Life Sciences & Biomedicine
(107)
Humans
(87)
Virology
(44)
Infectious Diseases
(39)
Biological And Medical Sciences
(37)
Aids/hiv
(35)
Hiv-1 - Immunology
(35)
Human Immunodeficiency Virus
(33)
Animals
(32)
Hiv
(32)
Human Immunodeficiency Virus 1
(32)
Medical Sciences
(29)
Molecular Sequence Data
(29)
Hiv Envelope Protein Gp120 - Immunology
(28)
Hiv-1
(28)
Immunology
(28)
Microbiology
(28)
Cell Line
(26)
Amino Acid Sequence
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prediction of Contact Residues in Anti-HIV Neutralizing Antibody by Deep Learning

Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron

Sensitivity to a CD4 mimic of a consensus clone of monkey-adapted CCR5-tropic SHIV-MK38C

Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2

Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitors

Osteoporosis-Related Fractures in HIV-Infected Patients Receiving Long-Term Tenofovir Disoproxil Fumarate: An Observational Cohort Study

Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors

Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop

Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies

Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates

Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19

Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG

Partial Splenic Embolization in a Patient with Hemophilia A and Severe Thrombocytopenia: A Case Report

Flexibility of small molecular CD4 mimics as HIV entry inhibitors

Clonality of HIV-1– and HTLV-1–Infected Cells in Naturally Coinfected Individuals

Apolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophages

Impact of maraviroc-resistant and low-CCR5-adapted mutations induced by in vitro passage on sensitivity to anti-envelope neutralizing antibodies

Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors

Phenotypic and Genotypic Co-receptor Tropism Testing in HIV-1 Epidemic Region of Tanzania Where Multiple Non-B Subtypes Co-circulate

Enhanced Exposure of Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Epitopes through Binding of CD4 Mimetic Compounds

The role of conventional antibodies targeting the CD4 binding site and CD4-induced epitopes in the control of HIV-1 CRF01_AE viruses

Complementary and synergistic activities of anti-V3, CD4bs and CD4i antibodies derived from a single individual can cover a wide range of HIV-1 strains

A minimally cytotoxic CD4 mimic as an HIV entry inhibitor

The Prevalence of High Antiretroviral Coverage and Viral Suppression in Japan: an Excellent Profile for a Downstream Human Immunodeficiency Virus Care Spectrum

CD4 mimics as HIV entry inhibitors: Lead optimization studies of the aromatic substituents

Suchergebnisse filtern